-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O4YQYPGK0ZfGhA072r7UZzSFZYVlMSxDlkHOVaHZmjFp8d5DpldZeHuaepkioH3A mYbTiSHqYhAO938y5JmOIQ== 0001105944-03-000066.txt : 20031230 0001105944-03-000066.hdr.sgml : 20031230 20031230140042 ACCESSION NUMBER: 0001105944-03-000066 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20031230 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DIKE ANTHONY C CENTRAL INDEX KEY: 0001105944 IRS NUMBER: 95429631 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 4127 W. 62ND STREET STREET 2: #500 CITY: LOS ANGELES STATE: CA ZIP: 90043 MAIL ADDRESS: STREET 1: 4127 W. 62ND STREET CITY: LOS ANGELES STATE: CA ZIP: 90043 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTERCARE DX INC CENTRAL INDEX KEY: 0001103310 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 954304537 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-79433 FILM NUMBER: 031077306 BUSINESS ADDRESS: STREET 1: 900 WILSHIRE BLVD #500 CITY: LOS ANGELES STATE: CA ZIP: 90017 BUSINESS PHONE: 213-627-8878 MAIL ADDRESS: STREET 1: 900 WILSHIRE BLVD #500 CITY: LOS ANGELES STATE: CA ZIP: 90017 FORMER COMPANY: FORMER CONFORMED NAME: INTERCARE COM DX INC DATE OF NAME CHANGE: 20010514 FORMER COMPANY: FORMER CONFORMED NAME: INTERCARE COM INC DATE OF NAME CHANGE: 20000114 SC 13D 1 aicsch13g.txt SCHEDULED 13D FILED ON 12/30/2003 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* InterCare DX, Inc. - ------------------------------------------------------------ (Name of Issuer) Common Stock, $0.0 par value - ------------------------------------------------------------ (Title of Class of Securities) 45845 - ------------------------------------------------------------ (CUSIP Number) Anthony C. Dike 900 Wilshire Blvd., Suite 500 Los Angeles, California (213) 627-8878 - ------------------------------------------------------------ (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 10, 1991 - ------------------------------------------------------------ (Date of Event which Requires Filling of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of (s)(s) 240.13d-1(e), 240.13d-1 (f) or 240.13d-1(g), check the following box. ( ) Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See (s) 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. 1 The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the note) - ------------------------------------------------------------------------------ SCHEDULE 13D CUSIP No. 45845 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. Anthony C. Dike, MD I.R.S. Identification No. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group* (a.) ( ) (b.) ( ) - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. Source of Funds* PF - -------------------------------------------------------------------------------- 5. Check if Disclosure of Legal Proceedings Is Required Pursuant to items 2(d) or 2(e) ( ) - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization USA - -------------------------------------------------------------------------------- Number of 7. Sole Voting Power 13,450,300 shares of Common Stock Shares Beneficially - ----------------------------------------------------------------- Owned 8. Shared Voting Power 0 by - ----------------------------------------------------------------- Each Reporting 9. Sole Dispositive Power 13,450,300 shares of Common Stock Person - ----------------------------------------------------------------- With 10. Shared Dispositive Power 0 - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 13,450,300 shares of Common Stock - -------------------------------------------------------------------------------- 12. Check if the Aggregate Amount Represented by Amount in Row (11) Excludes Certain Shares (See Instructions) ( ) - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 90.3% - -------------------------------------------------------------------------------- 14. Type of Reporting Person IN - -------------------------------------------------------------------------------- 2 ITEM 1. SECURITY AND ISSUER This Schedule 13D relates to the Common Stock, par value $0.0 per share ("Common Stock"), of InterCare DX, Inc., a California Corporation (the "Issuer"). The address of the principal executive office of the Issuer is 900 Wilshire Blvd Suite 500 Los Angeles, California. ITEM 2. IDENTITY AND BACKGROUND. (A) NAME: ANTHONY C. DIKE (b) Residence or business address: 900 Wilshire Blvd, Suite 500, Los Angeles, California 90017 (c) Present Principal Occupation or Employment: CEO, Chairman and a Director of the Issuer. (d) Criminal Conviction: During the last five years, the Reporting Person has not been convicted in a criminal proceeding. (e) Court or Administrative Proceedings: During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which resulted in a judgment, decree or final order (i) enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or (ii) finding a violation with respect to such laws. (f) Citizenship: United States of America. Item 3. Source and Amount of Funds or Other Consideration: Between December, 1991 thru 2000, the Reporting Person acquired beneficial ownership of 5,000,000 shares of Common Stock (adjusted for 100:1 stock split for initial start up cost and services rendered to the issuer. An additional 900,100 shares of Common Stock were issued to MMG Investments, Inc., an entity controlled by the reporting person, in consideration for an aggregate investment of $75,000 in the Issuer,(adjusted for 100:1 stock split). In December 1991, the Reporting Person was granted options to purchase Additional 500,000 shares of our common stock (adjusted for 100:1 stock split), exercisable until December 2001 In December 31, 2001, the Reporting Person acquired beneficial ownership of 500,000 shares of Common Stock through a grant by issuer of options to purchase a total of 500,000 shares of Common Stock at a purchase price of $0.002. These options are fully vested and must be exercised by the reporting person on or before December 31, 2001. In December 1992, the Reporting Person was granted options to purchase Additional 500,000 shares of our common stock (adjusted for 100:1 stock split), exercisable until December 2002 On December 31, 2002, the Reporting Person acquired beneficial ownership of additional 500,000 shares of Common Stock through a grant by issuer of options to purchase a total of 500,000 shares of Common Stock at a purchase price of $0.002. These options are fully vested and must be exercised by the reporting person on or before December 31, 2002. In December 1993, the Reporting Person was granted options to purchase Additional 500,000 shares of our common stock (adjusted for 100:1 stock split), exercisable until December 2003. On December 30, 2003, the Reporting Person acquired beneficial ownership of additional 500,000 shares of Common Stock through a grant by issuer of options to purchase a total of 500,000 shares of Common Stock at a purchase price of $0.002. These options are fully vested and must be exercised by the reporting person on or before December 31, 2003 In December 1994, the Reporting Person was granted options to purchase additional 500,000 shares of the issuer common stock at $0.002 per 3 share (adjusted for 100:1 stock split), exercisable until December 2004. In December 1995, the Reporting Person was granted options to purchase additional 500,000 shares of the issuer common stock at $0.002 per share (adjusted for 100:1 stock split), exercisable until December 2005. In December 1996, the Reporting Person was granted options to purchase Additional 500,000 shares of the issuer common stock at $0.002 per share (adjusted for 100:1 stock split), exercisable until December 2006. In December 1997, the Reporting Person was granted options to purchase Additional 500,000 shares of the issuer common stock at $0.002 per share (adjusted for 100:1 stock split), exercisable until December 2007. In December 1998, the Reporting Person was granted options to purchase additional 500,000 shares of the issuer common stock at $0.002 per share (adjusted for 100:1 stock split), exercisable until December 2008. In December 1999, the Reporting Person was granted options to purchase additional 500,000 shares of our common stock at $0.002 per share (adjusted for 100:1 stock split), exercisable until December 2009. In March 2000, the Reporting Person was granted options to purchase additional 250,000 shares of the issuer common stock at $5 per share, exercisable until December 2010. In January 2001, the Reporting Person was granted options to purchase additional 250,000 shares of the issuer common stock at $5 per share, exercisable until December 2006. In March 2002, the Reporting Person was granted options to purchase additional 100,000 shares of the issuer common stock at variable rate exercisable until December 2007. On April 10, 2003, Meridian Medical Group, P.C., and agreed to accept 3,600,200 common shares of the registrant from Meridian Holdings, Inc., with a fair market value of $360,020, based on the closing bid price of $0.10 per share as published in OTCBB website on that day, as a partial payment of debt owed to Meridian Medical Group P.C., in the amount of $714,833. The share certificate was received by Meridian Medical Group, P.C., on May 17, 2003. The reporting person owns all the issued and outstanding shares of Meridian Medical Group, P.C. In April 30, 2003, the Reporting Person disposed of 500,000 shares of Common Stock of the Issuer as a gift. Item 4. Purpose of Transaction State the purpose or purposes of the acquisition of securities of the issuer. Describe any plans or proposals which the reporting persons may have which relate to or would result in: The Reporting Person holds the Shares as reported herein for the purpose of investment. The Reporting Person plans to continue to acquire additional shares of Common Stock of the Issuer from time to time. Except as set forth in this Item 4, the Reporting Person has no present plans or proposals to acquire additional securities of the Company. However, the Reporting Person reserves the right from time to time to acquire additional securities and/or to dispose of securities and to participate in future transactions with respect to the Company's Securities. Upon a material change in the beneficial ownership of the Reporting Person, the Reporting Person will amend this Schedule 13D. Other than as described above, the Reporting Person has no plans or proposals which relate to, or may result in, any of the matters listed in items 4(a)-(j) of Schedule 13D. - ------------------------------------------------------------------------------- (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; 4 (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the issuer; (f) Any other material change in the issuer's business or corporate structure including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h) Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. Item 5. Interest in Securities of the Issuer. (a) The Reporting Person beneficially owns 13,450,300 shares of Common Stock, which represents 90.3% of the outstanding Common Stock. (b) The Reporting Person has sole power to vote or direct the vote of the Shares and sole power to dispose or direct the disposition of the Shares. (c) Not applicable. (d) Not applicable. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. None other than options disclosed in Item 4 above. - -------------------------------------------------------------------------------- Item 7. Material to be Filed as Exhibits. None. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: December 30, 2004 By: /s/ Anthony C. Dike -------------------- Anthony C. Dike 5 -----END PRIVACY-ENHANCED MESSAGE-----